The occurrence of multidrug-resistant bacterial pathogens (e.g., Enterobacterales and nonfermenting Gram-negative bacilli) to critically important antimicrobials such as carbapenems and colistin, last-resort antimicrobials, is a global multifactorial problem that involves animal–food–environmental–human sectors, which requires coordinated One Health and Global Health actions. The raising of food-producing animals has been increasing worldwide due to the rapid increase in demand for livestock products driven by human population growth. Consequently, the intensive use of antimicrobials in this sector has been associated with an increase in antimicrobial resistance. In this regard, the concerns associated with animal-to-human or animal-to-environment transmission of bacteria, including zoonotic pathogens, or plasmid-mediated antimicrobial resistance genes have increased in the last decade.
The main goals of this Research Topic are to fill in knowledge gaps on the epidemiology and genetic diversity of bacterial pathogens and antimicrobial resistance in livestock, and surrounding environments as well as to draw attention to the importance of this sector in the emergence of multidrug-, extensively drug-, and pandrug-resistant pathogens.
We welcome researchers to submit their scientific articles. Potential topics include, but are not limited to, the following:
• Patterns of emergence, spread, and evolution of bacterial strains, spotlighting high-risk clones.
• Whole-genome sequence-based analysis of bacteria from livestock or livestock-derived bacteria.
• Antimicrobial resistance in livestock and surrounding environments and its impact on Public Health.
• Association of antimicrobial resistance and virulence.
• Foodborne and waterborne illness caused by bacterial lineages of livestock origin.
• Impact of intensive use of antimicrobials in the food production chain.
• Effectiveness or not of the use of global action plans on antimicrobial resistance in livestock.
• Risk assessment as a tool of One Health policy design on antimicrobial resistance.
The occurrence of multidrug-resistant bacterial pathogens (e.g., Enterobacterales and nonfermenting Gram-negative bacilli) to critically important antimicrobials such as carbapenems and colistin, last-resort antimicrobials, is a global multifactorial problem that involves animal–food–environmental–human sectors, which requires coordinated One Health and Global Health actions. The raising of food-producing animals has been increasing worldwide due to the rapid increase in demand for livestock products driven by human population growth. Consequently, the intensive use of antimicrobials in this sector has been associated with an increase in antimicrobial resistance. In this regard, the concerns associated with animal-to-human or animal-to-environment transmission of bacteria, including zoonotic pathogens, or plasmid-mediated antimicrobial resistance genes have increased in the last decade.
The main goals of this Research Topic are to fill in knowledge gaps on the epidemiology and genetic diversity of bacterial pathogens and antimicrobial resistance in livestock, and surrounding environments as well as to draw attention to the importance of this sector in the emergence of multidrug-, extensively drug-, and pandrug-resistant pathogens.
We welcome researchers to submit their scientific articles. Potential topics include, but are not limited to, the following:
• Patterns of emergence, spread, and evolution of bacterial strains, spotlighting high-risk clones.
• Whole-genome sequence-based analysis of bacteria from livestock or livestock-derived bacteria.
• Antimicrobial resistance in livestock and surrounding environments and its impact on Public Health.
• Association of antimicrobial resistance and virulence.
• Foodborne and waterborne illness caused by bacterial lineages of livestock origin.
• Impact of intensive use of antimicrobials in the food production chain.
• Effectiveness or not of the use of global action plans on antimicrobial resistance in livestock.
• Risk assessment as a tool of One Health policy design on antimicrobial resistance.